Buradasınız

Anasayfa » Content

Propolis : Tıbbi Özellikleri ve Oftalmolojik Kullanımı

Propolis : medical properties and ophthalmologic use

Journal Name:

  • İnönü Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 1996

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Propolis is a natural hive product which is collected from buds, and produced by honey bee. The major compounds of propolis are flavonoids and caffeic acid esters which are also responsible for biologic activity of propolis. Propolis has been long used by folk medicine. It possesses versatile biologic activities proved on a scientific basis, including antimicrobial, antiinflammatory, regenerative, antioxidant, and cytostatic. We reviewed the current literature for propolis which is being more popular remedy recommended many different purposes. These properties of propolis may be new horizon in the treatment of some pathologies. [Journal of Turgut Özal Medical Center 1996;3(4):386-391]
Bookmark/Search this post with
Abstract (Original Language): 
Propolis bal arısı tarafından bitkilerden toplanıp kovanda üretilen doğal bir üründür. Flavonoidler ile kafeik asit ve esterleri propolisde en fazla bulunan ve biyolojik olarak aktif bileşenlerdir. Eski yıllardan beri halk hekimleri tarafından çeşitli hastalıkların tedavisinde kullanılagelen propolisin antimikrobik, antiinflamatuvar, rejeneratif antioksidan ve antineoplastik etkileri bilimsel çalışmalarla da ispatlanmıştır. Biz hergeçen gün popülaritesi artan ve çok farklı amaçlar için önerilen propolisle ilgili son literatürü gözden geçirdik ve özellikle antiinflamatuvar, antioksidan ve antineoplastik etkileriyle, topikal ve sistemik propolisin birçok patolojinin tedavisinde yeni ufuklar açabileceğini dikkatlere sunduk. [Turgut Özal Tıp Merkezi Dergisi 1996;3(4):386-391
FULL TEXT (PDF): 
PDF icon arastrmx_5674_3_pp_386-391.pdf
  • 4
386-391
  • Turkish

REFERENCES

References: 

1.
Dığra
k M, Yılmaz Ö, Çelik S, Yıldız S. Propolisteki yağ asitleri ve antimikrobiyal etkisi üzerinde in vitro araştırmalar. Gıda 1995; 20 (4): 249-55.
2.
Ivano
v DF, Tikonov AI, Krivenchuk PE, Liurskaia FV. Propolis and its clinical usage. Oftolmol Zh 1973; 28(2): 104¬7.
3.
Kayra
l N. Yeni Teknik Arıcılık; 5. baskı. İstanbul: Anka Ofset A.Ş. 1989; 13-4.
4. Krol W, Scheller S, Shani J, Pietsz G, Czubaz. Synergistic effect of ethanolic extract of propolis and antibiotics on the growth of staphylococcus aereus. Arzneimittelforschung 1993; 43(5): 607-9.
5. Bankova V, Dyulgerov A, Popov S, Evstatieva L, Kuleva L, Pureb O, Zamjansan Z. Propolis produced in Bulgaria and Mongolia: Phenolic compounds and plant origin. Apidologie
1992; 23: 79-85.
6. Greenaway W, Scaysbrook T, Whatley FR. The analysis of bud exsudate of populus X euramericana, and of propolis, by
gas chromatography-mass spectrometry. Proc R Soc Lond B 1987; 232: 249-72.
7. Garcia-Viguera C, Ferreres F, Tomas-Barberan FA. Study of Canadian propolis by GC-MS and HPLC. Z Naturforsch 1993;
48: 731-35.
8. Gabrys J, Konecki J, Krol W, Scheller S, Shani J. Free amino acids in bee hive products (Propolis) as identified and quantified by gas-liquid chromatography. Pharmacol Res
Comm 1986; 18(6): 513-18.
9.
Synergistic efect of flavones and flavonols against herpes simplex virus type 1 in cell culture: Comparison with the antiviral activity of propolis. J Nat Prod 1992; 55(12): 1732¬40.
10. Hausen BM, Wollenweber E. Propolis allergy: III. Sensitization studies with minor constituents. Contact Dermatitis 1988; 19: 296-303.
11. Ikeno K, Ikeno T, Myazawa C. Effects of propolis on dental caries in rats. Caries Res 1991; 25: 347-51.
12. Dobrowolski JW, Vohoraq SB, Sharma K, Shah SA, Naqvi SAH, Dandiya PC. Antibacterial, antifungal, antiamoebic, antiinflammatory, and antipyretic studies on propolis bee products. J Ethnopharmacol 1991; 35: 77-82.
13. Tikhonov AI, Sola DP. Liyofilize polifenolik propolis aköz preparation incelenmesi. Farm Zh 1976; 6: 40-44.
14. Golychev VN. Use of honey in conservative treatment of senile cataract. Vestn Oftalmol 1990; 106(6): 59-62.
15. Mozherenkov VP, Prokof'eva GL. Apitherapy of eye disease. Vestn Oftalmol 1991; 107 (6): 73-5.
16. Focht J, Hansen SH, Nielsen JV, van den Berg-Segers A, Riezler R. Bactericidal effect of propolis in vitro against agents causing upper respiratory tract infections. Arzneim Forsch/Drug Res 1993; 43(2): 921-23.
17. Amoros M, Lurton E, Boustie J, Girre L. Comparison of the anti-herpes simplex virus activities of propolis and 3-methyl-
but-2-enyl caffeate. J Nat Prod 1994; 57: 644-7.
18. Amaros M, Sauvager F, Girre L, Cormier M. In vitro antiviral activity of propolis. Apidologie 1992; 23: 231-40.
19. Khayyal MT, el-Ghazaly MA, el-Khatib AS. Mechanisms
involved in the antiinflammatory effect of propolis extract.
Drugs Exp Clin Res 1993; 19(5): 197-203.
20. Strehl E, Volpert R, Elstner EF. Biochemical activities of propolis extracts: III. Inhibition of dehydrofolate reductase. Z
Naturforsch 1994; 49(1-2): 39-43.
21. Mozherenkov VP, Miniaeva TG. The use of products from bee rasing in ophthalmology and otorhinolaringology. Med Sestra 1991; 50(11): 47-51.
22. Arvouet-Grand A, Lejeune B, Bastide P, Pourrat A, Privat AM, Legret P. Propolis extract: II. Wound healing in the rat
and rabbit. J Pharm Belg 1993; 48(3): 171-8.
23. Dimov V, Ivanovska N, Bankova V, Popov S. Immunomodulatory action of propolis: IV. Prophylactic activity against gram-negative infections and adjuvant effect of the water-soluble derivative. Vaccine 1992; 10 (12): 817.
24. Pascual C, Gonzales R, Torricella RG. Scavenging action of propolis extract against oxygen radicals. J Ethnopharmacol
1994; 41: 9-13.
25.
Sud'inaGF
, Mirzoeva OK, Pushkareva MA, Korshunova GA, Sumbatyan NV, Varfolomeev SD. Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties.
FEBS Lett 1993; 329: 21-4.
26. Krol W, Czuba Z, Scheller S, Gabrys J, Grabiec S, Shani J. Anti-oxidant property of etanolic extract of propolis (EEP) evaluated by inhibiting the chemiluminescence oxidation of
luminol. Biochem Int 1990; 21(4): 593-97.
27. Volpert R, Elstner EF. Biochemical activities of propolis extracts: II. Photodynamic activities. Z Naturforsch 1993; 48:
858-62.
28. Edenharder R, von Petersdorff I, Rauscher R. Antimutagenic effects of flavonoids, chalcones and structurally related
compound
s on the activity of 2-amino-3 methylimidazol [4,5-f]quinoline(IQ) and other heterocyclic amine mutagens from cooked food. Mutat Res 1993; 287(2): 261-74.
29. Grunberger D, Banerjee R, Eisinger K, Oltz EM, Efros L, Caldwell M, Estevez V, Nakanishi K. Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis. Experientia 1988; 44: 230-32.
30. Su ZZ, Lin J, Grunberger D, Fisher PB. Growth suppression and toxicity induced by caffeic acid phenetyl ester (CAPE) in type 5 adenovirus-transformed rat embryo cells correlate directly with transformation progression. Cancer Res 1994;
54: 1865-70.
31. Scheller S, Krol W, Swiacik J, Owczarek S, Gabrys J, Shani J. Antitumoral property of etanolic extract of propolis in mice-bearing Ehrlich carcinoma, as compared to bleomycin. Z Naturforsch 1989; 44 (11-12): 1063-5.
32. Starzyk J, Scheller S, Szaflarski J, Moskwa M, Stojko A. Biological properties and clinical application of propolis: II. Studies on the antiprotozoan activity of ethanol extract of propolis. Arzneim Forsch/Drug Res 1977; 27(1): 1198-99.
33. Grange JM, Davey RW. Antibacterial properties of propolis
(Bee Glue). J Royal Soci Med 1990; 83: 159-60.
34. Kleinrok Z, Borzecki Z, Scheller S, Matuga W. Biological properties and clinical application of propolis: X. Preliminary pharmacological evaluation of ethanol extract of propolis
(EEP). Arzneim Forsch/Drug Res 1978;28(1): 291-92.
35. Scheller S, Wilczok T, Imielski S, Krol W, Gabrys J, Shani J. Free radical scavenging by ethanol extract of propolis. Int J
Radiat Biol 1990; 57(3): 461-65.
36. Mirzoeva OK, Sudina GF, Pushkareva MA, Korshunova GA, Sumbatian NV, Varfolomeev SD. Lipophilic derivatives of caffeic acid as lipoxygenase inhibitors with antioxidant
properties. Bioorg Khim 1995; 21(2): 143-51.
37. Kaminski M, Scheller S, Nolewajka E. Biological properties and clinical application of propolis: V.The action of ethanol extract of propolis (EEP) on laboratory animals. Arzneim
Forsch/Drug Res 1977; 27(2): 1962-64.
38. Poole RC, Bowden NJ, Halestrap AP. Derivatives of cinnamic acid interact with the nucleotide binding site of mitochondrial aldehyde dehydrogenase. Effects on the dehydrogenase reaction and stimulation of esterase activity by nucleotides.
Biochem Pharmacol 1993; 45(8): 1621-30.
39. Frenkel K, Wei H, Bhimani R, Ye J, Zadunaisky JA, Huang MT, Ferraro T, Conney AH, Grunberger D. Inhibition of tumor promoter-mediated processes in mouse skin and bovine lens by caffeic asid phenethyl ester. Cancer Res 1993; 53: 1255-61.
40. Chiao C, Carothers AM, Grunberger D, Solomon G, Preston GA, Barrett JC. Apoptosis and altered redox state induced by caffeic acid phenethyl ester (CAPE) in transformed rat
fibroblast cells. Cancer Res 1995; 55: 3576-83.
41. Rao CV, Desai D, Simi B, Kulkarni N, Amin S, Reddy BS. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon. Cancer Res 1993; 53: 4182-88.
42. Rao CV, Desai D, Rivenson A, Simi B, Amin S, Reddy BS.
Chemoprevention of colon carcinogenesis by phenylethyl-3-methyl caffeate. Cancer Res 1995; 55: 2310-15.

Thank you for copying data from http://www.arastirmax.com